In Vitro Diagnostics Business Outlook, Volume 3, Issue 5 - Point-of-Care (POC)

23 Oct 2024

Categories:

In Vitro Diagnostics Business Outlook is a bimonthly publication with six issues annually.

In Vitro Diagnostics Business Outlook offers information and data that you cannot get anywhere else, including:

Market data and forecasts (growth rates, market size, market share, etc.) to identify growth opportunities
A comprehensive view of the IVD market with test categories covered and company briefs
M&A activities, selected partnerships & collaborations, partnership deals, and more
Industry & region watch to help tailor strategies
Analysis of news and events and reporting on news not easily available

Table of Contents

Market Analysis: IVD POC Testing
- Overview of IVD POC Testing
- Market Outlook
  - Selected Product Activity
- Regional Market
- Company Briefs
  - Abbott Diagnostics
  - Dexcom
  - Roche
Executive News Briefing
- Briefs
  - Quanterix Appoints New Member to Board of Directors
  - Beckman Coulter Appoints New President
  - MARAbio Raises $19 Million in Series A Funding
  - Amprion Makes Advances in Series B Financing
  - Sunbird Bio Closes $14 Million Financing Round
  - Bruker Reported 17% Growth in Second Quarter 2024 and 11% Growth for the First Six Months
  - Myriad Genetics Reports 13% Revenue Growth in First Half 2024
Diagnostic Market Mergers, Acquisitions and Partnership Deals
- Partnerships and Collaborations
- Mergers and Acquisitions
Industry Watch
- Industry Watch COVID-19/Flu Update
Region Watch
- Finland
Broad-based Company Announcements
- Announcements
  - Roche Launches TAGS Technology Test
  - Exact Sciences Welcomes New Cologuard Plus Test
  - PreAnalytiX Launches PAXgene Urine Liquid Biopsy Set
  - Abionic Launches Early Sepsis Test
  - QIAGEN Expands Liquid Biopsy Portfolio
  - FoundationOne Gains Liquid CDx Approval
  - Revvity’s Euroimmun Announces Groundbreaking Launch in the EU

Attachments